Loss of TLR3 and its downstream signaling accelerates acinar cell damage in the acute phase of pancreatitis.


Journal

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
ISSN: 1424-3911
Titre abrégé: Pancreatology
Pays: Switzerland
ID NLM: 100966936

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 11 09 2018
revised: 06 12 2018
accepted: 14 12 2018
pubmed: 26 12 2018
medline: 23 4 2019
entrez: 26 12 2018
Statut: ppublish

Résumé

Acute pancreatitis is accompanied by acinar cell damage releasing potential toll-like receptor 3 (TLR3) ligands. So far, TLR3 is known as a pattern recognition receptor in the immune signaling cascade triggering a type I interferon response. In addition, TLR3 signaling contributes to programmed cell death through the activation of caspase 8. However, the functional role of TLR3 and its downstream toll-like receptor adaptor molecule 1 (TICAM1) in the inflamed pancreas is unknown. To uncover the role of TLR3 signaling in acute pancreatitis, we induced a cerulein-mediated pancreatitis in Tlr3 and Ticam1 knockout (KO) mice and in wildtype animals. The exocrine damage was determined by blood serum analysis and histological examination. Immunohistochemistry, gene expression and immunoblot analysis were conducted to study TLR3 function. After the induction of an acute pancreatitis, wildtype mice showed a high endosomal TLR3 expression in acinar cells. In comparison to wildtype and Ticam1 KO mice, Tlr3 KO mice exhibited the highest severity of pancreatitis with an increased NF-κB activation and elevated expression of the pro-inflammatory cytokines Il6 and Tnf, although the amount of infiltrating immune cells was unaffected. Additionally, we detected a strong elevation of acinar cell necrosis and reduced levels of cleaved caspase 8 in Tlr3 and Ticam1 KO mice. TLR3 and its downstream adaptor TICAM1 are important mediators of acinar cell damage in acute pancreatitis. They possess a critical role in programmed cell death and our data suggest that TLR3 signaling controls the onset and severity of acute pancreatitis.

Sections du résumé

BACKGROUND BACKGROUND
Acute pancreatitis is accompanied by acinar cell damage releasing potential toll-like receptor 3 (TLR3) ligands. So far, TLR3 is known as a pattern recognition receptor in the immune signaling cascade triggering a type I interferon response. In addition, TLR3 signaling contributes to programmed cell death through the activation of caspase 8. However, the functional role of TLR3 and its downstream toll-like receptor adaptor molecule 1 (TICAM1) in the inflamed pancreas is unknown.
METHODS METHODS
To uncover the role of TLR3 signaling in acute pancreatitis, we induced a cerulein-mediated pancreatitis in Tlr3 and Ticam1 knockout (KO) mice and in wildtype animals. The exocrine damage was determined by blood serum analysis and histological examination. Immunohistochemistry, gene expression and immunoblot analysis were conducted to study TLR3 function.
RESULTS RESULTS
After the induction of an acute pancreatitis, wildtype mice showed a high endosomal TLR3 expression in acinar cells. In comparison to wildtype and Ticam1 KO mice, Tlr3 KO mice exhibited the highest severity of pancreatitis with an increased NF-κB activation and elevated expression of the pro-inflammatory cytokines Il6 and Tnf, although the amount of infiltrating immune cells was unaffected. Additionally, we detected a strong elevation of acinar cell necrosis and reduced levels of cleaved caspase 8 in Tlr3 and Ticam1 KO mice.
CONCLUSIONS CONCLUSIONS
TLR3 and its downstream adaptor TICAM1 are important mediators of acinar cell damage in acute pancreatitis. They possess a critical role in programmed cell death and our data suggest that TLR3 signaling controls the onset and severity of acute pancreatitis.

Identifiants

pubmed: 30583980
pii: S1424-3903(18)30766-X
doi: 10.1016/j.pan.2018.12.005
pii:
doi:

Substances chimiques

Adaptor Proteins, Vesicular Transport 0
TICAM-1 protein, mouse 0
TLR3 protein, mouse 0
Toll-Like Receptor 3 0
Ceruletide 888Y08971B

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-157

Informations de copyright

Copyright © 2018 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Auteurs

Ivonne Regel (I)

Department of Medicine II, University Hospital, LMU Munich, Germany. Electronic address: ivonne.regel@med.uni-muenchen.de.

Susanne Raulefs (S)

Department of Surgery, Klinikum rechts der Isar, Technical University Munich, Germany.

Simone Benitz (S)

Department of Medicine II, University Hospital, LMU Munich, Germany.

Charlotte Mihaljevic (C)

Department of Surgery, Klinikum rechts der Isar, Technical University Munich, Germany; Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany.

Simon Rieder (S)

Department of Surgery, Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany.

Georg Leinenkugel (G)

Department of Surgery, Klinikum rechts der Isar, Technical University Munich, Germany.

Katja Steiger (K)

Institute of Pathology, Technical University Munich, Germany.

Anna Melissa Schlitter (AM)

Institute of Pathology, Technical University Munich, Germany.

Irene Esposito (I)

Institute of Pathology, Heinrich-Heine University and University Hospital, Duesseldorf, Germany.

Julia Mayerle (J)

Department of Medicine II, University Hospital, LMU Munich, Germany.

Bo Kong (B)

Department of Surgery, Klinikum rechts der Isar, Technical University Munich, Germany.

Jörg Kleeff (J)

Department of Surgery, Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany.

Christoph W Michalski (CW)

Department of Surgery, Martin-Luther University Halle-Wittenberg, Halle (Saale), Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH